Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_727d2d6da6d3eadb944d63bb12dcc30a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
filingDate |
2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c6bdfc57d0cc6ce8a1e2c8bcfa05e8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_697fa0b378715aeb510de368dd9c2c92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_053b8ba8e0b1e9228f458de5cc92c43a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eccb9a6640fa7dd8183e4ab1ab9cff9b |
publicationDate |
2022-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2022188850-A1 |
titleOfInvention |
Anti-tumor combined preparation comprising hydroxyprogesterone caproate and use thereof |
abstract |
Provided in the present invention is a pharmaceutical composition comprising hydroxyprogesterone caproate and an additional therapeutic agent for treating tumors, wherein the additional therapeutic agent is preferably a monoclonal antibody against PD-1 or PD-L1. Further provided in the present invention are a method for increasing the number of tumor infiltrating lymphocytes (TIL) as required and a method for treating cancers in a subject in need thereof, which comprises providing the hydroxyprogesterone caproate to the subject. |
priorityDate |
2021-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |